API reference
Ropinirole
- CAS number
- 91374-21-9
- Molecular formula
- C16H24N2O
- Molecular weight
- 260.37 g/mol
About this molecule
Ropinirole, also known as ReQuip, is a non-ergoline dopamine agonist used in Parkinson's disease and restless legs syndrome,. It is manufactured by GlaxoSmithKline Pharmaceuticals. Ropinirole was initially approved in 1997 by the FDA for the management of Parkinson's disease. In 2005, it was the first drug approved in the US for the management of primary moderate to severe restless legs syndrome. In 2008, the extended-release capsules of ropinirole were approved, allowing for less frequent dosing, therefore increased compliance, and offering a similar side effect profile and efficacy to previous formulations of ropinirole.
Source: DrugBank, via PubChem.
Identifiers
- IUPAC name
- 4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one
- InChIKey
- UHSKFQJFRQCDBE-UHFFFAOYSA-N
- SMILES
- CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
- PubChem CID
- 5095
Also known as
ropinirole · ropinirol · Ropinirolum · Ropitor · Narapin · Adartrel · 2H-Indol-2-one, 4-(2-(dipropylamino)ethyl)-1,3-dihydro- · 4-(2-(Dipropylamino)ethyl)-1,3-dihydro-2H-indol-2-one
Related entries in the range
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.